PENICILLIN RESISTANT PNEUMOCOCCI IN FRANCE AND BETA-LACTAM AGENTS - UPDATE OF THE CENTER-NATIONAL-DE-REFERENCE

被引:27
作者
GESLIN, P
FREMAUX, A
SISSIA, G
机构
[1] Centre National de Référence des Pneumocoques, GEEP, Service de Microbiologie, 94000 Créteil
来源
MEDECINE ET MALADIES INFECTIEUSES | 1991年 / 21卷 / 4BIS期
关键词
PENICILLIN RESISTANT PNEUMOCOCCI; BETA-LACTAM AGENTS; TREATMENT;
D O I
10.1016/S0399-077X(05)81405-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Since 1987, penicillin-resistant pneumococci are isolated with increasing frequency in France without reaching anyway the percentage reported in South Africa, Spain, Hungary. Those strains are often multiply resistant pneumococci. Thus detection of these strains appears to be now necessary. Penicillin and all beta-lactam antibiotics show higher MICs against these strains, however among beta-lactam antibiotics different degrees of resistance can be observed. Imipenem, amoxicillin and injectable thrid generation cephalosporins remain the most active. These molecules have bactericidal activity at 2xMIC or 4xMIC. MICs of first, second and third oral cephalosporins against these strains are over their blood levels. Blood level with cefuroxime axetil and cefpodoxime proxetil just reach the MICs of resistant strains. According to the bacteriological and pharmacocinetic data, most active beta-lactam antibiotics are imipenem, amoxicillin, cefotaxime and ceftriaxone and then penicillin and ampicillin. Against resistant strains (MICs greater-than-or-equal-to 4 mg/l) vancomycin seems to be the best choice.
引用
收藏
页码:3 / 11
页数:9
相关论文
共 15 条
  • [1] Acar, Begue, Humbert, Vachon, Tables d'Antibiothérapie de l'Assistance Publique de Paris, (1989)
  • [2] Appelbaum, Bhamjee, Scragg, Hallet, Bowen, Cooper, Streptococcus pneumoniae resistant to penicillin and chloramphenicol, Lancet, 2, pp. 995-997, (1977)
  • [3] Appelbaum, Koornhof, Jacobs, Et al., Multiple antibiotic-resistance of pneumococci-South Africa, Morbid. Mortal. Weekly Rep., 26, pp. 285-286, (1977)
  • [4] Boussougant, Weber, Activité comparée du céfixime et de sept autres béta-lactamines vis-à-vis de Streptococcus pneumoniae La Presse Médicale, 18, pp. 1553-1555, (1989)
  • [5] Dabernat, Avril, Boussougant, In vitro activity of cefpodoxime against pathogens responsible for community-acquired respiratory tract infections, Journal of Antimicrobial Chemotherapy, 26, pp. 1-6, (1990)
  • [6] Dublanchet, Durieux, Isolement d'une souche de Streptococcus pneumoniae multirésistante aux antibiotiques, Nouv. Presse Méd., 8, (1979)
  • [7] Geslin, Rapport du Centre National de Référence du Pneumocoque (Année 1987), B.E.H., 7, pp. 25-27, (1989)
  • [8] Geslin, Fremaux, Sissia, Résistance du pneumocoque aux antibiotiques, La Lettre de l'Infectiologue, 4, pp. 695-704, (1989)
  • [9] Geslin, Rapport du Centre National de Référence du Pneumocoque (Année 1989), B.E.H., 2, pp. 6-7, (1991)
  • [10] Jacobs, Koornhof, Robins-Browne, Stevenson, Vermaak, Freiman, Miller, Witcomb, Isaacson, Ward, Austrian, Emergence of multiply resistant pneumococci, N. Engl. J. Med., 299, pp. 735-740, (1978)